Search
for
Sort by
Research 91–120 of 107
- Recent Advances in Drug Development for Hair Loss
- Managing Common Dermatologic Needs in Transgender and Gender-Diverse Adolescents
- Idiopathic Alopecia—A Retrospective Descriptive Study Integrated with the Current Literature
- Topical, light-based, and complementary interventions for acne: an overview of systematic reviews
- Genomic Markers and Personalized Medicine in Androgenetic Alopecia: A Comprehensive Review
- Effects of Nannochloropsis salina Fermented Oil on Proliferation of Human Dermal Papilla Cells and Hair Growth
- Androgenetic Alopecia in Men: An Update On Genetics
- Tổng quan các phương pháp điều trị rụng tóc do nội tiết tố
- Androgenetic Alopecia: update on Etiology, Pathophysiology, Diagnosis and Treatment
- The Hormonal Background of Hair Loss in Non-Scarring Alopecias
- The Biology and Genomics of Human Hair Follicles: A Focus on Androgenetic Alopecia
- The Pathogenesis and Treatment Progress of Androgenic Alopecia
- The association of cytosine-adenine-guanine repeat polymorphism in the androgen receptor gene with nodulocystic acne in Egyptian patients
- Cell Therapy for Androgenetic Alopecia: Elixir or Trick?
- Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs
- An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin Cancer
- New Drugs for Alopecias
- Clascoterone: First Approval
- Use of topical clascoterone for the treatment of hidradenitis suppurativa
- Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist
- Clascoterone as a novel treatment for androgenetic alopecia
- Biological Profile of Cortexolone 17a-Propionate (CB-03-01), a New Topical and Peripherally Selective Androgen Antagonist
- Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream
- Cortexolone 17α-Propionate (Clascoterone) is an Androgen Receptor Antagonist in Dermal Papilla Cells In Vitro
- A summary of in vitro, phase I, and phase II studies evaluating the mechanism of action, safety, and efficacy of clascoterone (cortexolone 17a propionate, CB-03-01) in androgenetic alopecia
- A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity
- Clascoterone in the Treatment of Acne Vulgaris: A Narrative Review
- BRIDGING THE GAP IN ACNE MANAGEMENT: A NARRATIVE REVIEW OF CURRENT THERAPIES AND THE EMERGENCE OF CLASCOTERONE
- 0951 Breezula, a clinical stage topical anti-androgen, promotes dermal papilla inductivity and reduces IL-6 secretion in balding skin samples ex vivo
- Clascoterone Cream 1% in Acne Management: Case Series and Real-World Canadian Experience